SEC Form D · filed February 22, 2022
Shuttle Pharmaceuticals Holdings, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Mira Jung · Rockville, MDExecJoshua Schafer · Rockville, MDDirectorAnatoly Dritschilo · Rockville, MDExec · DirectorChris Senanayake · Rockville, MDDirectorMilton Brown · Rockville, MDExec · DirectorMichael Vander Hoek · Rockville, MDExecTyvin Rich · Rockville, MDExecWilliam Adkins · Rockville, MDDirectorSteven Richards · Rockville, MDDirectorPeter Dritschillo · Rockville, MDExecAmy R. Fauss · Leawood, KSDirectorBenjamin R. Clouse · Leawood, KSExecJames W. Kuykendall · Leawood, KSExecBen Deda · Denver, COExecRobert Schultz · Denver, CODirectorPeter Oberle · Denver, COExecAmy C. Abrams · Leawood, KSExec · DirectorGeorge E. Hansen Iii · Leawood, KSExec · DirectorAZM Asset Management, LP · Houston, TXDirectorSteven W. Caple · Leawood, KSDirectorLisa M. Longino · Jersey City, NJDirectorGulshan R. Ramgoolam · Ebene, O4ExecTooram R. Gopall · Ebene, O4ExecMark R. Shenkman · New York, NYDirectorDan J. Cohrs · Vancouver, British Columbia, CanadaDirectorDavid S. Urquhart · Woollahra, Channel IslandsExec · DirectorArthur D. Hyde, Iv · West Palm Beach, FLExec · DirectorAdam Rodman · West Palm Beach, FLExecJun Li · PETALUMA, CAExecMark Weinberg · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗